Hematopoietic Stem Cell Transplantation and High Dose Chemotherapy in Recurrent and/or Chemotherapy Resistant Hodgkin Lymphoma Cases: A Single Center Experience

Hematopoietic Stem Cell Transplantation and High Dose Chemotherapy in Recurrent and/or Chemotherapy Resistant Hodgkin Lymphoma Cases: A Single Center Experience

Background: Nearly 20% of patients with Hodgkin Lymphoma (HL) who receive standard treatment will relapse or have a refractory disease. Standard treatment for the Relapsed/Refractory (RR) HL is salvage high dose chemotherapy followed by autologous stem cell transplantation (AuSCT). Management of RR...

Full description

Saved in:
Bibliographic Details
Main Authors: Yöntem Yaman, Murat Elli, Kürşat Özdilli, Leyla Telhan, Nihan Bayram, Volkan Hazar, Ebru Tuğrul Sarıbeyoğlu, Şifa Şahin, Seniye Sema Anak
Format: Article
Language:English
Published: Istanbul University Press 2021-05-01
Series:Çocuk Dergisi
Subjects:
brentuximab vedotin
check point inhibitör
high dose chemotherapy
hodgkin lymphoma
stem cell
relapse
transplantation
Online Access:https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/C8B967475A7D4AC8BC4D423D70C3C8EB
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://cdn.istanbul.edu.tr/file/JTA6CLJ8T5/C8B967475A7D4AC8BC4D423D70C3C8EB

Similar Items